Pharma Bio Serv Stock Analysis
| PBSV Stock | USD 0.61 0.11 22.00% |
Pharma Bio Serv is overvalued with Real Value of 0.43 and Hype Value of 0.5. The main objective of Pharma Bio otc analysis is to determine its intrinsic value, which is an estimate of what Pharma Bio Serv is worth, separate from its market price. There are two main types of Pharma Bio's stock analysis: fundamental analysis and technical analysis.
The Pharma Bio otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Pharma |
Pharma OTC Stock Analysis Notes
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharma Bio Serv last dividend was issued on the 24th of February 2022. Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.The quote for Pharma Bio Serv is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Pharma Bio Serv contact Victor Sanchez at 787 278 2709 or learn more at https://www.pharmabioserv.com.Pharma Bio Serv Investment Alerts
| Pharma Bio Serv had very high historical volatility over the last 90 days | |
| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| About 65.0% of the company outstanding shares are owned by corporate insiders |
Pharma Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharma Bio's market, we take the total number of its shares issued and multiply it by Pharma Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Pharma Profitablity
Pharma Bio's profitability indicators refer to fundamental financial ratios that showcase Pharma Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Pharma Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pharma Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pharma Bio's profitability requires more research than a typical breakdown of Pharma Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Technical Drivers
As of the 12th of December 2024, Pharma Bio holds the Variance of 36.16, coefficient of variation of (2,696), and Risk Adjusted Performance of (0.02). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharma Bio, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for Pharma Bio Serv, which can be compared to its competitors. Please check Pharma Bio Serv market risk adjusted performance and treynor ratio to decide if Pharma Bio Serv is priced some-what accurately, providing market reflects its current price of 0.61 per share. As Pharma Bio Serv is a penny stock we also suggest to check out its jensen alpha numbers.Pharma Bio Serv Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pharma Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pharma Bio Serv. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Pharma Bio Outstanding Bonds
Pharma Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharma Bio Serv uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharma bonds can be classified according to their maturity, which is the date when Pharma Bio Serv has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| PHARMACIA P 66 Corp BondUS71713UAW27 | View | |
| PHARMACIA P 675 Corp BondUS71713UAT97 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Pharma Bio Predictive Daily Indicators
Pharma Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pharma Bio otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.22 | |||
| Day Median Price | 0.61 | |||
| Day Typical Price | 0.61 | |||
| Price Action Indicator | 0.055 | |||
| Period Momentum Indicator | 0.11 |
Pharma Bio Forecast Models
Pharma Bio's time-series forecasting models are one of many Pharma Bio's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharma Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Pharma OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharma Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharma shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Pharma Bio. By using and applying Pharma OTC Stock analysis, traders can create a robust methodology for identifying Pharma entry and exit points for their positions.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Pharma Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.